dog |
LD50 |
oral |
706mg/kg (706mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Cardiovascular Drug Reviews. Vol. 8, Pg. 105, 1990. |
mouse |
LD50 |
intravenous |
44mg/kg (44mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Cardiovascular Drug Reviews. Vol. 8, Pg. 105, 1990. |
mouse |
LD50 |
oral |
300mg/kg (300mg/kg) |
|
European Patent Application. Vol. #159566, |
mouse |
LD50 |
subcutaneous |
> 1200mg/kg (1200mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Cardiovascular Drug Reviews. Vol. 8, Pg. 105, 1990. |
rat |
LD50 |
intravenous |
27mg/kg (27mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Cardiovascular Drug Reviews. Vol. 8, Pg. 105, 1990. |
rat |
LD50 |
oral |
307mg/kg (307mg/kg) |
|
Cardiovascular Drug Reviews. Vol. 8, Pg. 105, 1990. |
rat |
LD50 |
subcutaneous |
882mg/kg (882mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Cardiovascular Drug Reviews. Vol. 8, Pg. 105, 1990. |